DCTH
Price:
$9.76
Market Cap:
$312.06M
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphal...[Read more]
Industry
Medical - Specialties
IPO Date
2018-05-03
Stock Exchange
NASDAQ
Ticker
DCTH
According to Delcath Systems, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 306.82M. This represents a change of 77.97% compared to the average of 172.40M of the last 4 quarters.
The mean historical Enterprise Value of Delcath Systems, Inc. over the last ten years is 15.29M. The current 306.82M Enterprise Value has changed 200.55% with respect to the historical average. Over the past ten years (40 quarters), DCTH's Enterprise Value was at its highest in in the December 2016 quarter at 6.96B. The Enterprise Value was at its lowest in in the December 2014 quarter at -20466165.00.
Average
15.29M
Median
7.98M
Minimum
-20466165.00
Maximum
65.06M
Discovering the peaks and valleys of Delcath Systems, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 85.68%
Maximum Annual Enterprise Value = 65.06M
Minimum Annual Increase = -499.04%
Minimum Annual Enterprise Value = -20466165.00
Year | Enterprise Value | Change |
---|---|---|
2023 | 65.06M | 62.18% |
2022 | 40.12M | -17.85% |
2021 | 48.83M | 85.68% |
2020 | 26.30M | -499.04% |
2019 | -6590625.00 | -194.16% |
2018 | 7.00M | -289.59% |
2017 | -3691875.00 | -141.22% |
2016 | 8.96M | -171.08% |
2015 | -12600385.00 | -38.43% |
2014 | -20466165.00 | -34.50% |
The current Enterprise Value of Delcath Systems, Inc. (DCTH) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
51.34M
5-year avg
34.74M
10-year avg
15.29M
Delcath Systems, Inc.’s Enterprise Value is less than NeuroPace, Inc. (347.61M), less than Surmodics, Inc. (554.56M), greater than ProSomnus, Inc. Common Stock (40.81M), less than CVRx, Inc. (310.32M), less than LivaNova PLC (3.12B), greater than Electromed, Inc. (238.10M), less than OrthoPediatrics Corp. (611.40M), greater than TELA Bio, Inc. (142.23M), less than TransMedics Group, Inc. (2.74B), greater than Telesis Bio, Inc. (30.77M), greater than AVITA Medical, Inc. (273.50M), less than ClearPoint Neuro, Inc. (308.59M), greater than Sight Sciences, Inc. (120.25M), less than Treace Medical Concepts, Inc. (545.80M), greater than Pulmonx Corporation (260.62M), less than IRadimed Corporation (623.15M), less than Orthofix Medical Inc. (829.81M), less than Integer Holdings Corporation (5.77B),
Company | Enterprise Value | Market cap |
---|---|---|
347.61M | $289.53M | |
554.56M | $561.12M | |
40.81M | $8.18M | |
310.32M | $360.32M | |
3.12B | $2.79B | |
238.10M | $251.96M | |
611.40M | $637.85M | |
142.23M | $118.56M | |
2.74B | $2.55B | |
30.77M | $1.62M | |
273.50M | $349.74M | |
308.59M | $326.46M | |
120.25M | $203.53M | |
545.80M | $487.79M | |
260.62M | $268.12M | |
623.15M | $674.61M | |
829.81M | $722.63M | |
5.77B | $4.63B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Delcath Systems, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Delcath Systems, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Delcath Systems, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Delcath Systems, Inc. (DCTH)?
What is the 3-year average Enterprise Value for Delcath Systems, Inc. (DCTH)?
What is the 5-year average Enterprise Value for Delcath Systems, Inc. (DCTH)?
How does the current Enterprise Value for Delcath Systems, Inc. (DCTH) compare to its historical average?